Clinical Observation of Yinzhihuang Oral Liquid in the Adjuvant Treatment of Neonatal Breast-feeding Faun-dice / 中国药房
China Pharmacy
; (12): 5090-5092, 2015.
Article
en Zh
| WPRIM
| ID: wpr-501343
Biblioteca responsable:
WPRO
ABSTRACT
OBJECTIVE:To observe the clinical efficacy and safety of Yinzhihuang oral liquid in the adjuvant treatment of neo-natal breast-feeding faundice. METHODS:112 newborns with faundice were randomly divided into control group and observation group. Control group stopped breast-feeding for 3 d and given artificial feeding,as well as keeping warm,nutritional support, maintaining water and electrolyte and acid-base balance,blue light irradiation and severe patients were given liver protection,en-zyme inducers;observation group was additionally given Yinzhihuang oral liquid 10 ml,twice a day. The treatment course was 7 d. Clinical efficacy,and serum total bilirubin(TBIL)level before and after treatment,and incidence of adverse reactions in 2 groups were observed. RESULTS:The total effective rate in observation group was significantly higher than control group,the difference was statistically significant(P0.05). CONCLUSIONS:Based on the conventional treatment,Yinzhihuang oral liquid can be used in the adjuvant treatment of neonatal breast-feeding faundice,with good efficacy and good safety.
Texto completo:
1
Base de datos:
WPRIM
Idioma:
Zh
Revista:
China Pharmacy
Año:
2015
Tipo del documento:
Article